Your session is about to expire
← Back to Search
VBI-S for Low Blood Pressure in Septic Shock
Study Summary
This trial is testing a drug to see if it can raise blood pressure in patients with septic shock who have low blood volume.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has this method been federally regulated?
"This treatment received a safety rating of 2. This is due to the fact that it is only in Phase 2 trials, meaning while there is evidence supporting its safety, there are no studies yet which suggest it is an effective intervention."
Are there a lot of hospitals participating in this research project within the state?
"Currently, this study is enrolling patients at Einstine Medical Center in East Norriton, Pennsylvania, Dignity Health in Chandler, Arizona, and Henry Ford Health System in Detroit, Michigan. There are 10 other locations where recruitment is happening."
Is this research still looking for volunteers?
"The listed clinical trial on clinicaltrials.gov is still recruiting patients, with the study having been posted on February 17th, 2020 and edited as recently as October 26th, 2020."
What is the total number of participants in this test?
"In order for this clinical trial to move forward, 20 patients that meet the pre-determined criteria must be recruited. The sponsor, Vivacelle Bio, has chosen various locations across America to conduct the trial; two examples are Einstine Medical Center in East Norriton, Pennsylvania and Dignity Health in Chandler, Arizona."
Share this study with friends
Copy Link
Messenger